COVID-19和凝血病之间的相互关系:病理生理学和临床证据
Beatrice Ragnoli1, Beatrice Da Re1, Alessandra Galantino1
1Respiratory Unit, Sant'Andrea Hospital, 13100 Vercelli, Italy.
COVID-19 感染导致高凝血状态,称为COVID-19 相关凝血病 (CAC),增加了血栓栓塞事件的风险. 了解CAC机制对于开发新的血管疗法至关重要.
科学领域:
- * 内部医学 内部医学
- * 病理学 病理学
- * 血管医学 血管医学
背景情况:
- *COVID-19感染具有多样化的临床表现,特别是高发生率的血栓栓塞事件.
- *这些事件可能会发展为急性呼吸系统应急综合征 (ARDS) 和COVID-19相关的凝血病 (CAC).
- * CAC中的高凝血状态是由血栓形成和炎症之间的相互作用引起的,这显着导致器官损伤.
研究的目的:
- *为COVID-19感染中的凝血病的病原性机制提供全面的概述.
- * 探索有关COVID-19相关凝血病 (CAC) 的当前知识.
- * 确定和讨论新兴的研究领域和新的血管治疗策略.
主要方法:
- * 本研究是对现有文献的叙事性综述.
- * 它综合了COVID-19相关凝血病的病理生理学信息.
- * 该审查审查了拟议的机制和潜在的治疗干预措施.
主要成果:
- *COVID-19相关的凝血病 (CAC) 的特征是D-二次体,淋巴细胞,纤维素原,IL-6 (IL-6) 和延长的前激素时间的水平升高.
- * 假设的机制包括炎症性细胞因子风暴,血小板激活,内皮功能障碍和静止.
- * 审查强调了CAC在COVID-19病原和器官损伤中的关键作用.
结论:
- *COVID-19相关的凝血病 (CAC) 是一种严重的并发症,由炎症和血栓形成之间的复杂相互作用驱动.
- *对CAC机制的更深入的理解对于有效的患者管理至关重要.
- *对新型血管治疗策略的进一步研究是有必要的,以解决COVID-19的这一关键方面.
更多相关视频
09:19In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
